[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578068":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":20,"responsibleParty":38,"collaborators":7,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":42,"sex":48,"minAge":49,"maxAge":7,"enrollmentInfo":50,"targetDuration":7,"studyType":53,"phases":7,"briefSummary":54,"conditions":55,"keywords":7,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Pier Luigi Zinzani, MD","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+39 0512143680","pierluigi.zinzani@unibo.it",{"name":18,"role":14,"phone":15,"phoneExt":7,"email":19},"Alessandro Broccoli, MD","Alessandro.broccoli@studio.unibo.it",[21],{"facility":22,"status":23,"city":24,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"IRCCS Azienda Ospedaliero - Universitaria di Bologna","RECRUITING","Bologna","40138","Italy","IT",{"type":29,"coordinates":30},"Point",[31,32],11.33875,44.49381,{"lat":32,"lon":31},[35,37],{"name":10,"role":14,"phone":36,"phoneExt":7,"email":16},"+390512143680",{"name":18,"role":14,"phone":15,"phoneExt":7,"email":19},{"type":39,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100578068","study-to-assess-clinical-characteristics-and-outcome-of-patients-with-marginal-zone-lymphomas-100578068",false,"NCT06806488","Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas","Retrospective Observational Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas","MarZoLyOss","Inclusion Criteria:\n\n1. Marginal zone lymphoma patients who were diagnosed and treated in our Hospital between December 2012 and December 2018.\n2. Age ≥ 18 years at enrolment.\n3. Written informed consent (if applicable)\n\nExclusion Criteria:\n\n* none","ALL","18 Years",{"count":51,"type":52},160,"ESTIMATED","OBSERVATIONAL","This is a purely retrospective and observational monocentric study",[56],"Marginal Zone B Cell Lymphoma","2025-01-28",{"date":59,"type":60},"2025-02-04","ACTUAL",{"date":62,"type":52},"2025-05",{"date":64,"type":52},"2025-10",{"name":5,"class":6},1]